Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway

Tanshinone IIA (TS IIA), a multi-pharmaceutical compound from traditional Chinese herb, is effective for treatment of atherothrombosis. However, the underlying mechanisms of TS IIA-mediated anti-platelet activ...

Source: BMC Cardiovascular Disorders - February 14, 2020 Category: Cardiology Authors: Hua Wang, Lin Zhong, Shaohua Mi, Nianpeng Song, Wei Zhang and Ming Zhong Tags: Research article Source Type: research